Jackson N, Mustapha M, Baba A A
Department of Medicine, Hospital Universiti Sains Malaysia, Kubang, Kerian, Kelantan.
Med J Malaysia. 1995 Sep;50(3):250-5.
In this part of Malaysia, consent of splenectomy is virtually unobtainable, so we studied the outcome of ITP without this treatment option. Thirty-two adult patients were seen, but 7 defaulted before therapy evaluation. Of the remaining 25, 17 achieved a complete remission with prednisolone, but in only 8 was this prolonged. Twelve patients, who failed to respond to prednisolone or who required > 15 mg/day as maintenance, were offered splenectomy, but all fused. Of these 12: one has died from an intracranial haemorrhage; three others have defaulted while on no treatment with platelet counts of < 16 x 10(9)/1; one has had a baby who died from intracranial bleeding. The other seven patients have platelet counts ranging from 4 - 202 x 10(9)/1 with moderate bleeding on doses of prednisolone of 0-60 mg/day: long-term corticosteroid side-effect are evident in all but one of them. This study demonstrates that ITP patients who refuse splenectomy have a high morbidity.
在马来西亚的这个地区,几乎无法获得脾切除术的同意书,因此我们研究了没有这种治疗选择的特发性血小板减少性紫癜(ITP)的治疗结果。我们诊治了32例成年患者,但有7例在治疗评估前就不再前来。在其余25例中,17例使用泼尼松龙后实现完全缓解,但只有8例缓解得以持续。12例对泼尼松龙无反应或维持治疗时需要>15mg/天的患者被建议进行脾切除术,但他们均拒绝了。在这12例患者中:1例死于颅内出血;另外3例在未接受治疗且血小板计数<16×10⁹/L时不再前来;1例生育了1名死于颅内出血的婴儿。其他7例患者的血小板计数在4 - 202×10⁹/L之间,服用0 - 60mg/天的泼尼松龙时有中度出血:除1例之外,其他患者均出现明显的长期皮质类固醇副作用。本研究表明,拒绝脾切除术的ITP患者发病率很高。